Mass. Movers

Danvers’ Abiomed falls on downgrade

Abiomed’s AbioCor Total Replacement Heart.


Abiomed’s AbioCor Total Replacement Heart.


Shares of Danvers-based Abiomed Inc. fell following a downgrade from overweight to neutral by analysts at Piper Jaffray. They are concerned over balancing risks related to Food and Drug Administration premarket approval, and benefits from opportunities including a growing product pipeline, new markets like Japan, and favorable reimbursements. Abiomed develops, manufactures, and markets technologies designed to help or replace the pumping function of the heart.

Loading comments...
Real journalists. Real journalism. Subscribe to The Boston Globe today.